|
Volumn 50, Issue 3, 2000, Pages 245-249
|
Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: A phase II study
a,b a a a c a a |
Author keywords
Chemotherapy; Docetaxel; Glioma
|
Indexed keywords
CORTICOSTEROID;
DEXAMETHASONE;
DOCETAXEL;
NITROSOUREA;
ONDANSETRON;
STEROID;
ADULT;
AGED;
ARTICLE;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
FEMALE;
GLIOBLASTOMA;
HUMAN;
MALE;
MULTIMODALITY CANCER THERAPY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
RECURRENT CANCER;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BRAIN NEOPLASMS;
FEMALE;
GLIOMA;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
SURVIVAL RATE;
TAXOIDS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0034477835
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006494032052 Document Type: Article |
Times cited : (38)
|
References (16)
|